8-K - Polaryx Therapeutics, Inc. (0002075320) (Filer)

Filed: 2026-05-28 AccNo: 0001213900-26-062155 Size: 275 KB Item 1.01: Entry into a Material Definitive Agreement Item 3.02: Unregistered Sales of Equity Securities Item 7.01: Regulation FD Disclosure Item 9.01: Financial Statements and Exhibits